Surgery, Gastroenterology and Oncology
Vol. 25, No. 5, Dec 2020
Primary Splenic Melanoma Associated with Small Intestinal Serosal Implants Causing Intussusception - A Case Report
Omar Hamdy, Gehad A Saleh, Sara Raafat, Mohammad Zuhdy, Abdelhadi M Shebl
Images in Clinical Medicine, Dec 2020
Article DOI: 10.21614/sgo-25-5-286
Introduction: Melanoma is a highly aggressive tumor that carries a poor prognosis. There are several reported cases of secondary splenic melanoma but there is only one reported case of primary splenic melanoma yet. Case presentation: A 35-year-old male, complaining from left lumbar pain.
Abdominal ultrasound revealed a mass at the lower pole of the spleen measuring 10x7x7 cm. Computed Tomography (CT) described a necrotic focal lesion involving its lower pole measuring 11 x 9 cm. US-guided fine needle aspiration (FNA) was suggestive of lymphoma, but tissue biopsy was recommended.
So, the patient underwent open diagnostic splenectomy which revealed the diagnosis of malignant melanoma. Only two weeks after being discharged from the hospital, he was re-admitted by acute intestinal obstruction for which he underwent exploration which revealed an ileo-ileal intussusception near the ileocecal junction with multiple pigmented malignant nodules on the wall of the small intestine. Resection of the involved small intestinal part including intussusception was done.
Pathological examination revealed malignant melanoma infiltrating the whole intestinal wall thickness from outside (confirming its metastatic nature) and infiltration of the mesenteric LN by the same tumor tissue. The patient died 6 months later after being diagnosed with brain metastasis.

Conclusion: Primary splenic melanoma is extremely rare with only one reported case in literature. This report is not only unique because of the rarity of the primary splenic melanoma but the intussusception caused by melanomatous serosal deposits is extremely rare as well.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2467


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.